Minerva Neurosciences (NERV) Assets Average (2014 - 2026)

Minerva Neurosciences' Assets Average history runs 13 years deep, the most recent figure standing at $96.0 million for Q1 2026.

• Quarterly Assets Average rose 174.51% year-over-year to $96.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.0 million (up 174.51% YoY) and the FY2025 annual result came in at $67.6 million, up 43.67% from the prior year.
• Assets Average was $96.0 million for Q1 2026 at Minerva Neurosciences, up from $63.0 million in the prior quarter.
• Across five years, Assets Average topped out at $96.0 million in Q1 2026 and bottomed at $29.3 million in Q3 2025.
• A 5-year average of $55.3 million and a median of $57.4 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average tumbled 38.53% — and 2026, when it surged 174.51%.
• Minerva Neurosciences' Assets Average stood at $57.4 million in 2022, then advanced by 4.51% to $60.0 million in 2023, then slumped by 33.39% to $40.0 million in 2024, then surged by 57.66% to $63.0 million in 2025, then surged by 52.3% to $96.0 million in 2026.
• Business Quant data shows NERV's Assets Average at $96.0 million in Q1 2026, $63.0 million in Q4 2025, and $29.3 million in Q3 2025.